Inappropriate use of proton pump inhibitors in a local setting
There are growing concerns that the use of proton pump inhibitors (PPIs) may be inappropriate in instances that do not conform to evidence-based indications. This point-prevalence study aimed to investigate the frequency, indications and appropriateness of use of PPIs in hospitalised patients on a r...
Saved in:
Published in | Singapore medical journal Vol. 55; no. 7; pp. 363 - 366 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Singapore
Singapore Medical Association
01.07.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | There are growing concerns that the use of proton pump inhibitors (PPIs) may be inappropriate in instances that do not conform to evidence-based indications. This point-prevalence study aimed to investigate the frequency, indications and appropriateness of use of PPIs in hospitalised patients on a randomly chosen day.
On a randomly chosen day, all inpatients were documented, and those on any form of PPIs on that day were determined. Indications for maintaining these patients on PPIs were obtained from the electronic medical records, which were then recorded and cross-referenced against a list of accepted indications adapted from the US Food and Drug Administration (FDA)-approved list.
In all, 1,025 inpatients were documented. Of the 477 (46.5%) inpatients using PPIs, only 219 (45.9%) fulfilled the FDA-approved indications, while the majority (n = 258, 54.1%) did not. Overall, PPIs were not strictly indicated for use in 206 (43.2%) inpatients, according to FDA criteria. Of the 477 inpatients on PPIs, 52 (10.9%) had borderline indications based on expert consensus/guidelines other than FDA criteria.
Although the use of PPIs is prevalent in hospitals, less than half of the hospitalised patients using PPIs in our study had evidence-based indications that supported such use. The overuse of PPIs has a negative impact on healthcare costs and may lead to adverse effects. Steps to curb the inappropriate use of PPIs should address factors such as indications for the initiation of PPIs, and reassessment of the need for ongoing PPI use in inpatients upon discharge and during outpatient reviews. |
---|---|
AbstractList | INTRODUCTIONThere are growing concerns that the use of proton pump inhibitors (PPIs) may be inappropriate in instances that do not conform to evidence-based indications. This point-prevalence study aimed to investigate the frequency, indications and appropriateness of use of PPIs in hospitalised patients on a randomly chosen day. METHODSOn a randomly chosen day, all inpatients were documented, and those on any form of PPIs on that day were determined. Indications for maintaining these patients on PPIs were obtained from the electronic medical records, which were then recorded and cross-referenced against a list of accepted indications adapted from the US Food and Drug Administration (FDA)-approved list. RESULTSIn all, 1,025 inpatients were documented. Of the 477 (46.5%) inpatients using PPIs, only 219 (45.9%) fulfilled the FDA-approved indications, while the majority (n = 258, 54.1%) did not. Overall, PPIs were not strictly indicated for use in 206 (43.2%) inpatients, according to FDA criteria. Of the 477 inpatients on PPIs, 52 (10.9%) had borderline indications based on expert consensus/guidelines other than FDA criteria. CONCLUSIONAlthough the use of PPIs is prevalent in hospitals, less than half of the hospitalised patients using PPIs in our study had evidence-based indications that supported such use. The overuse of PPIs has a negative impact on healthcare costs and may lead to adverse effects. Steps to curb the inappropriate use of PPIs should address factors such as indications for the initiation of PPIs, and reassessment of the need for ongoing PPI use in inpatients upon discharge and during outpatient reviews. There are growing concerns that the use of proton pump inhibitors (PPIs) may be inappropriate in instances that do not conform to evidence-based indications. This point-prevalence study aimed to investigate the frequency, indications and appropriateness of use of PPIs in hospitalised patients on a randomly chosen day. On a randomly chosen day, all inpatients were documented, and those on any form of PPIs on that day were determined. Indications for maintaining these patients on PPIs were obtained from the electronic medical records, which were then recorded and cross-referenced against a list of accepted indications adapted from the US Food and Drug Administration (FDA)-approved list. In all, 1,025 inpatients were documented. Of the 477 (46.5%) inpatients using PPIs, only 219 (45.9%) fulfilled the FDA-approved indications, while the majority (n = 258, 54.1%) did not. Overall, PPIs were not strictly indicated for use in 206 (43.2%) inpatients, according to FDA criteria. Of the 477 inpatients on PPIs, 52 (10.9%) had borderline indications based on expert consensus/guidelines other than FDA criteria. Although the use of PPIs is prevalent in hospitals, less than half of the hospitalised patients using PPIs in our study had evidence-based indications that supported such use. The overuse of PPIs has a negative impact on healthcare costs and may lead to adverse effects. Steps to curb the inappropriate use of PPIs should address factors such as indications for the initiation of PPIs, and reassessment of the need for ongoing PPI use in inpatients upon discharge and during outpatient reviews. |
Author | Chia, Christopher Tze Wei Lim, Wan Peng Vu, Charles Kien Fong |
AuthorAffiliation | 1 Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore |
AuthorAffiliation_xml | – name: 1 Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore |
Author_xml | – sequence: 1 givenname: Christopher Tze Wei surname: Chia fullname: Chia, Christopher Tze Wei email: christopher_tw_chia@ttsh.com.sg organization: Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433. christopher_tw_chia@ttsh.com.sg – sequence: 2 givenname: Wan Peng surname: Lim fullname: Lim, Wan Peng – sequence: 3 givenname: Charles Kien Fong surname: Vu fullname: Vu, Charles Kien Fong |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25091884$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkE1PwzAMhnMYYh9w5Yhy5NKRpEmaXiahiY9Jk7jAOUo7Z8vUJqVpkfj3lG1McLJlv35tP1M08sEDQjeUzCmVjN3HGjb7OSOUE5WN0ISQNEuEzMQYTWPcE8IyotQlGjNBcqoUn6DFypumaUPTOtMB7iPgYPFQ6ILHTV832PmdK1wX2jik2OAqlKbCEbrO-e0VurCminB9ijP0_vT4tnxJ1q_Pq-XDOim5kF0CjBZKULWhmbA2NcZywoQkVHImSyaZtXkuNozkIEEWBeMEgBsFVJWpsjSdocXRt-mL4ckSfNeaSg9X16b90sE4_b_j3U5vw6fmLKe5_DG4Oxm04aOH2OnaxRKqyngIfdRUCCopS3k2SOdHadmGGFuw5zWU6ANofQCtT6CHgdu_x53lv5TTbwuffqY |
CitedBy_id | crossref_primary_10_1007_s11096_015_0178_0 crossref_primary_10_1007_s40266_019_00703_7 crossref_primary_10_47583_ijpsrr_2022_v76i01_011 crossref_primary_10_3390_ijerph19148739 crossref_primary_10_1002_lary_27916 crossref_primary_10_1096_fj_202101986R crossref_primary_10_1016_j_bpg_2019_04_002 crossref_primary_10_1177_23992026211062729 crossref_primary_10_2174_1574886315666200311120151 crossref_primary_10_1016_j_rgmxen_2017_07_002 crossref_primary_10_3389_fphar_2020_552102 crossref_primary_10_47102_annals_acadmedsg_20226 crossref_primary_10_1016_j_revmed_2015_04_014 crossref_primary_10_1111_jcpt_12613 crossref_primary_10_33713_egetbd_1070299 crossref_primary_10_1111_jgh_13875 crossref_primary_10_3389_fmed_2024_1345144 crossref_primary_10_1097_SGA_0000000000000500 crossref_primary_10_11622_smedj_2018153 crossref_primary_10_3177_jnsv_62_330 crossref_primary_10_3389_fphar_2024_1383698 crossref_primary_10_1016_j_mcna_2018_08_001 crossref_primary_10_1159_000515116 crossref_primary_10_4103_singaporemedj_SMJ_2023_008 crossref_primary_10_1007_s41999_020_00380_5 crossref_primary_10_7759_cureus_27149 crossref_primary_10_3390_ijerph18094422 crossref_primary_10_1097_MD_0000000000009089 crossref_primary_10_47102_annals_acadmedsg_2021308 crossref_primary_10_57187_smw_2023_40119 crossref_primary_10_1016_j_sapharm_2016_02_012 crossref_primary_10_2196_13896 crossref_primary_10_1016_j_rgmx_2016_12_007 crossref_primary_10_1590_1806_9282_66_7_913 crossref_primary_10_3390_jcm12062262 crossref_primary_10_1007_s11845_018_1891_1 crossref_primary_10_1016_j_ajg_2021_06_003 |
Cites_doi | 10.1111/j.1572-0241.2000.02680.x 10.1046/j.1365-2710.2000.00312.x 10.2174/157488410793352067 10.1002/pds.3387 10.1097/MEG.0b013e3282f52f95 10.2169/internalmedicine.49.4064 10.2146/ajhp060393 10.1097/SMJ.0b013e3181ce0e7a 10.1016/j.jamda.2007.07.001 10.1038/ajg.2009.115 10.1016/j.ejim.2010.11.009 10.1093/ndt/18.3.570 10.1007/s10620-005-3052-4 10.18553/jmcp.2010.16.2.122 |
ContentType | Journal Article |
Copyright | Copyright: © Singapore Medical Association 2014 |
Copyright_xml | – notice: Copyright: © Singapore Medical Association 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.11622/smedj.2014087 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 366 |
ExternalDocumentID | 10_11622_smedj_2014087 25091884 |
Genre | Journal Article |
GeographicLocations | United States Singapore |
GeographicLocations_xml | – name: Singapore – name: United States |
GroupedDBID | --- .55 123 2WC 53G AAWTL ACGFO ADBBV AEGXH AENEX AIAGR ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CUY CVF DIK E3Z EBD EBS ECM EIF EJD EMOBN EOJEC F5P GX1 HYE NPM OBODZ OK1 OVD P2P RPM SV3 TEORI TR2 WOQ X7M XSB ZXP AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c456t-e21b8518d175ff3aaf40256016426c262ff995d209e6e6bb240ee4a8e18c38f13 |
IEDL.DBID | RPM |
ISSN | 0037-5675 |
IngestDate | Fri Sep 01 02:33:27 EDT 2023 Thu Apr 11 15:25:00 EDT 2024 Fri Aug 23 04:04:28 EDT 2024 Thu May 23 23:55:52 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c456t-e21b8518d175ff3aaf40256016426c262ff995d209e6e6bb240ee4a8e18c38f13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://smj.org.sg/sites/default/files/5507/5507a2.pdf |
PMID | 25091884 |
PQID | 1551612347 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4291961 proquest_miscellaneous_1551612347 crossref_primary_10_11622_smedj_2014087 pubmed_primary_25091884 |
PublicationCentury | 2000 |
PublicationDate | 2014-07-01 |
PublicationDateYYYYMMDD | 2014-07-01 |
PublicationDate_xml | – month: 07 year: 2014 text: 2014-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Singapore |
PublicationPlace_xml | – name: Singapore |
PublicationTitle | Singapore medical journal |
PublicationTitleAlternate | Singapore Med J |
PublicationYear | 2014 |
Publisher | Singapore Medical Association |
Publisher_xml | – name: Singapore Medical Association |
References | ref13 ref15 ref14 ref11 (ref4) 2012; 32 ref17 ref16 ref18 ref8 ref7 ref9 ref3 ref6 ref5 Chavez-Tapia (ref10) 2008; 14 Thomas (ref2) 2010; 16 Heidelbaugh (ref1) 2010; 16 Bez (ref12) 2012; 19 |
References_xml | – volume: 32 start-page: 44 issn: 10225129 year: 2012 ident: ref4 publication-title: Rev Gastroenterol Peru – ident: ref7 doi: 10.1111/j.1572-0241.2000.02680.x – ident: ref18 doi: 10.1046/j.1365-2710.2000.00312.x – ident: ref6 doi: 10.2174/157488410793352067 – ident: ref8 doi: 10.1002/pds.3387 – ident: ref11 doi: 10.1097/MEG.0b013e3282f52f95 – ident: ref3 doi: 10.2169/internalmedicine.49.4064 – ident: ref15 doi: 10.2146/ajhp060393 – volume: 19 start-page: 378 issn: 13561294 year: 2012 ident: ref12 article-title: Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department. publication-title: J Eval Clin Pract contributor: fullname: Bez – ident: ref9 doi: 10.1097/SMJ.0b013e3181ce0e7a – volume: 14 start-page: CR468 issn: 12341010 year: 2008 ident: ref10 article-title: Use and overuse of proton pump inhibitors in cirrhotic patients. publication-title: Med Sci Monit contributor: fullname: Chavez-Tapia – ident: ref14 doi: 10.1016/j.jamda.2007.07.001 – volume: 16 start-page: e228 issn: 10880224 year: 2010 ident: ref1 article-title: Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. publication-title: Am J Manag Care contributor: fullname: Heidelbaugh – ident: ref5 doi: 10.1038/ajg.2009.115 – ident: ref13 doi: 10.1016/j.ejim.2010.11.009 – ident: ref17 doi: 10.1093/ndt/18.3.570 – ident: ref16 doi: 10.1007/s10620-005-3052-4 – volume: 16 start-page: 122 issn: 10834087 year: 2010 ident: ref2 article-title: Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization. publication-title: J Manag Care Pharm doi: 10.18553/jmcp.2010.16.2.122 contributor: fullname: Thomas |
SSID | ssj0027088 |
Score | 2.2455919 |
Snippet | There are growing concerns that the use of proton pump inhibitors (PPIs) may be inappropriate in instances that do not conform to evidence-based indications.... INTRODUCTIONThere are growing concerns that the use of proton pump inhibitors (PPIs) may be inappropriate in instances that do not conform to evidence-based... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 363 |
SubjectTerms | Anemia - drug therapy Dyspepsia - drug therapy Electronic Health Records Hospitalization Humans Inappropriate Prescribing - statistics & numerical data Original Platelet Aggregation Inhibitors - therapeutic use Practice Guidelines as Topic Prevalence Proton Pump Inhibitors - therapeutic use Retrospective Studies Singapore Stomach Diseases - drug therapy United States United States Food and Drug Administration |
Title | Inappropriate use of proton pump inhibitors in a local setting |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25091884 https://search.proquest.com/docview/1551612347 https://pubmed.ncbi.nlm.nih.gov/PMC4291961 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwGA1zB_Ei_nb-IoLgqWubpl16EWQ4pjDx4GC30qQJq7i02O7_90vaDqc3b4UmJXz5mvceefmC0B2gNlUk4A6gmQCBwqUTS487sScYDxmM3TcHnGev0XROXxbhoofC7iyMNe0Lng_152qo86X1VpYr4XY-MfdtNoY1FBLHd3fQDsBvJ9E7leWxZvkNRk4IdLit1OhHhLgVIMyH8XNRj5nr94iBS8boNij9YZq_DZM_EGhygPZb6ogfmyEeop7UR2h31m6OH6OHZ20rhJeQU7XE60riQmFTiKHQuIRpw7le5jw39-vAI06xBTJcSet9PkHzydP7eOq01yM4AlhP7Ujic-BLLAMGoFSQpoo2AgskRSRIRJSK4zAjXiwjGXEO2C0lTZn0mQiY8oNT1NeFlucIg0gK4MdPJVEjGnsh99KMZgzkRCagExmg-y4-SdlUwUiseoCgJjaoSRvUAbrtwpdAoprdh1TLYl0ldksOcJJCm7MmnJtvdfMwQKOtQG8amCLY228gN2wx7DYXLv7d8xLtmbE3Ftwr1K-_1vIaiEbNb2xifQOD1NKj |
link.rule.ids | 230,314,727,780,784,885,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dS8MwFL3MCeqL-O38jCD4VNemaZe-CCKOTbfhg4JvpWkTVnHpcNv_9yZth9M33wptSnpym3MOubkBuEbWZor6wkE2S9GgCOlE0hVO5KZcBBz77pkNzsNR2HtjT-_BewOCei-MTdpPRX6rPye3Oh_b3MrpJG3XeWLtl-EDzqEYOF57DdYDvxN5tUmvfZbLywnY7zgBCuKqVqMXUtqeIcd8mIwu5nJzAB81hMk5W6WlP1rzd8rkDw7q7sB2JR7JfdnJXWhIvQcbw2p5fB_u-trWCJ9iVM0lWcwkKRQxpRgKTaY4cCTX41zk5oQdvCQJsVRGZtJmPx_AW_fx9aHnVAckOCnqnrkjqSdQMfEMNYBSfpIoVlosNBVhSkOqVBQFGXUjGcpQCGRvKVnCpcdTnyvPP4SmLrQ8BoI2ycdfP5FUdVjkBsJNMpZxNBRZio1oC25qfOJpWQcjtv4BQY0tqHEFaguuavhiDFWz_pBoWSxmsV2UQ6Zk-MxRCefyXfU4tKCzAvTyAVMGe_UORocth11Fw8m_W17CZu91OIgH_dHzKWyZ7ygTcs-gOf9ayHOUHXNxYYPsG8Zv1fg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA46YXgRfzt_RhA81bZp2qUXQaZjUzd2cLBbadqEVVxa3Pb_-5K2Y9Obt0KTkr685vs-3ut7CN0BalNJPG4BmiUgULiwQuFwK3QSxn0Ga3f1D86DYdAb09eJP1lr9WWS9hOePaiv2YPKpia3spgldp0nZo8GHThDwXFcu0ilvY12fA-crBbqtdZyWHkIe23LB1Jc1Wt0A0LsOeDMp87qog7TTfiIBk3G6CY0_eGbv9Mm13Cou4_2KgKJn8qFHqAtoQ5Rc1CFyI_QY1-ZOuEFeNZC4OVc4FxiXY4hV7iAzcOZmmY801124BLH2MAZnguTAX2Mxt2Xj07PqpokWAlwn4UliMuBNbEUeICUXhxLWsosEBZBQgIiZRj6KXFCEYiAc0BwIWjMhMsSj0nXO0ENlStxhjBIJQ8-_1gQ2aah43MnTmnKQFSkCUwiLXRf2ycqyloYkdEQYNTIGDWqjNpCt7X5InBXHYOIlciX88gE5gAtKYw5Lc25ela9Dy3U3jD0aoAuhb15BzzElMSuPOL83zNvUHP03I3e-8O3C7SrX6PMyb1EjcX3UlwB81jwa-NjP-y-1ws |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inappropriate+use+of+proton+pump+inhibitors+in+a+local+setting&rft.jtitle=Singapore+medical+journal&rft.au=Chia%2C+Christopher+Tze+Wei&rft.au=Lim%2C+Wan+Peng&rft.au=Vu%2C+Charles+Kien+Fong&rft.date=2014-07-01&rft.pub=Singapore+Medical+Association&rft.issn=0037-5675&rft.volume=55&rft.issue=7&rft.spage=363&rft.epage=366&rft_id=info:doi/10.11622%2Fsmedj.2014087&rft_id=info%3Apmid%2F25091884&rft.externalDBID=PMC4291961 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0037-5675&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0037-5675&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0037-5675&client=summon |